These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 28523591)

  • 1. Assessment of the Neuroprotective Effects of Arginine-Rich Protamine Peptides, Poly-Arginine Peptides (R12-Cyclic, R22) and Arginine-Tryptophan-Containing Peptides Following In Vitro Excitotoxicity and/or Permanent Middle Cerebral Artery Occlusion in Rats.
    Meloni BP; Milani D; Cross JL; Clark VW; Edwards AB; Anderton RS; Blacker DJ; Knuckey NW
    Neuromolecular Med; 2017 Sep; 19(2-3):271-285. PubMed ID: 28523591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of neuroprotective efficacy of poly-arginine R18 and R18D (D-enantiomer) peptides following permanent middle cerebral artery occlusion in the Wistar rat and in vitro toxicity studies.
    Milani D; Bakeberg MC; Cross JL; Clark VW; Anderton RS; Blacker DJ; Knuckey NW; Meloni BP
    PLoS One; 2018; 13(3):e0193884. PubMed ID: 29513757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poly-arginine peptides reduce infarct volume in a permanent middle cerebral artery rat stroke model.
    Milani D; Clark VW; Cross JL; Anderton RS; Knuckey NW; Meloni BP
    BMC Neurosci; 2016 May; 17(1):19. PubMed ID: 27142074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative Assessment of the Proteolytic Stability and Impact of Poly-Arginine Peptides R18 and R18D on Infarct Growth and Penumbral Tissue Preservation Following Middle Cerebral Artery Occlusion in the Sprague Dawley Rat.
    Milani D; Clark VW; Feindel KW; Blacker DJ; Bynevelt M; Edwards AB; Anderton RS; Knuckey NW; Meloni BP
    Neurochem Res; 2021 May; 46(5):1166-1176. PubMed ID: 33523394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterisation of neuroprotective efficacy of modified poly-arginine-9 (R9) peptides using a neuronal glutamic acid excitotoxicity model.
    Edwards AB; Anderton RS; Knuckey NW; Meloni BP
    Mol Cell Biochem; 2017 Feb; 426(1-2):75-85. PubMed ID: 27844251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Neuroprotective Peptide Poly-Arginine-12 (R12) Reduces Cell Surface Levels of NMDA NR2B Receptor Subunit in Cortical Neurons; Investigation into the Involvement of Endocytic Mechanisms.
    MacDougall G; Anderton RS; Edwards AB; Knuckey NW; Meloni BP
    J Mol Neurosci; 2017 Feb; 61(2):235-246. PubMed ID: 27866326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Poly-arginine and arginine-rich peptides are neuroprotective in stroke models.
    Meloni BP; Brookes LM; Clark VW; Cross JL; Edwards AB; Anderton RS; Hopkins RM; Hoffmann K; Knuckey NW
    J Cereb Blood Flow Metab; 2015 Jun; 35(6):993-1004. PubMed ID: 25669902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro cellular uptake and neuroprotective efficacy of poly-arginine-18 (R18) and poly-ornithine-18 (O18) peptides: critical role of arginine guanidinium head groups for neuroprotection.
    MacDougall G; Anderton RS; Ouliel E; Gao J; Redmond SL; Knuckey NW; Meloni BP
    Mol Cell Biochem; 2020 Jan; 464(1-2):27-38. PubMed ID: 31679100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroprotective peptides fused to arginine-rich cell penetrating peptides: Neuroprotective mechanism likely mediated by peptide endocytic properties.
    Meloni BP; Milani D; Edwards AB; Anderton RS; O'Hare Doig RL; Fitzgerald M; Palmer TN; Knuckey NW
    Pharmacol Ther; 2015 Sep; 153():36-54. PubMed ID: 26048328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Poly-arginine R18 and R18D (D-enantiomer) peptides reduce infarct volume and improves behavioural outcomes following perinatal hypoxic-ischaemic encephalopathy in the P7 rat.
    Edwards AB; Cross JL; Anderton RS; Knuckey NW; Meloni BP
    Mol Brain; 2018 Feb; 11(1):8. PubMed ID: 29426351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delayed 2-h post-stroke administration of R18 and NA-1 (TAT-NR2B9c) peptides after permanent and/or transient middle cerebral artery occlusion in the rat.
    Milani D; Cross JL; Anderton RS; Blacker DJ; Knuckey NW; Meloni BP
    Brain Res Bull; 2017 Oct; 135():62-68. PubMed ID: 28964774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroprotective efficacy of poly-arginine R18 and NA-1 (TAT-NR2B9c) peptides following transient middle cerebral artery occlusion in the rat.
    Milani D; Cross JL; Anderton RS; Blacker DJ; Knuckey NW; Meloni BP
    Neurosci Res; 2017 Jan; 114():9-15. PubMed ID: 27639457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteomic analysis of cortical neuronal cultures treated with poly-arginine peptide-18 (R18) and exposed to glutamic acid excitotoxicity.
    MacDougall G; Anderton RS; Mastaglia FL; Knuckey NW; Meloni BP
    Mol Brain; 2019 Jul; 12(1):66. PubMed ID: 31315638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring the role of MKK7 in excitotoxicity and cerebral ischemia: a novel pharmacological strategy against brain injury.
    Vercelli A; Biggi S; Sclip A; Repetto IE; Cimini S; Falleroni F; Tomasi S; Monti R; Tonna N; Morelli F; Grande V; Stravalaci M; Biasini E; Marin O; Bianco F; di Marino D; Borsello T
    Cell Death Dis; 2015 Aug; 6(8):e1854. PubMed ID: 26270349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The neuroprotective efficacy of cell-penetrating peptides TAT, penetratin, Arg-9, and Pep-1 in glutamic acid, kainic acid, and in vitro ischemia injury models using primary cortical neuronal cultures.
    Meloni BP; Craig AJ; Milech N; Hopkins RM; Watt PM; Knuckey NW
    Cell Mol Neurobiol; 2014 Mar; 34(2):173-81. PubMed ID: 24213248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poly-arginine-18 (R18) Confers Neuroprotection through Glutamate Receptor Modulation, Intracellular Calcium Reduction, and Preservation of Mitochondrial Function.
    MacDougall G; Anderton RS; Trimble A; Mastaglia FL; Knuckey NW; Meloni BP
    Molecules; 2020 Jun; 25(13):. PubMed ID: 32610439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of R18, COG1410, and APP96-110 in Excitotoxicity and Traumatic Brain Injury.
    Chiu LS; Anderton RS; Cross JL; Clark VW; Edwards AB; Knuckey NW; Meloni BP
    Transl Neurosci; 2017; 8():147-157. PubMed ID: 29177102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GIF-0173 protects against cerebral infarction through DP1 receptor activation.
    Thura M; Hokamura K; Yamamoto S; Maeda M; Furuta K; Suzuki M; Ibaraki K; Umemura K
    Exp Neurol; 2009 Oct; 219(2):481-91. PubMed ID: 19576888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroprotective effect of a novel Chinese herbal decoction on cultured neurons and cerebral ischemic rats.
    Ip FC; Zhao YM; Chan KW; Cheng EY; Tong EP; Chandrashekar O; Fu GM; Zhao ZZ; Ip NY
    BMC Complement Altern Med; 2016 Nov; 16(1):437. PubMed ID: 27814708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurotrophic and neuroprotective effects of oxyntomodulin in neuronal cells and a rat model of stroke.
    Li Y; Wu KJ; Yu SJ; Tamargo IA; Wang Y; Greig NH
    Exp Neurol; 2017 Feb; 288():104-113. PubMed ID: 27856285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.